Filter posts

Medical Research from Mars Can Fail Patients from Venus

Historically, federal dollars inadvertently flowed to medical research with a disproportionate focus on men’s health. …

BIO Latin America to Showcase Brazil’s Agricultural Breakthroughs

Brazil’s vast, fertile landscape – covering 47 percent of the South American continent – is …

Senate Has the Power to Expand Access to Medication for Opioid Addiction

BIO President and CEO Jim Greenwood posted the following op-ed on Linked-In today, making the …

My Pledge at World Congress: BIO Will Lead on Gene Editing

This year marks the 15th anniversary of BIO’s World Congress on Industrial Biotechnology, as well …

Debunking a Common Myth on Out-of-Pocket Costs

The facts continue to show that, when it comes to prescription drug costs, the country …

Greenwood comment on PABNAB

BIO and BIO’s Board-level Workforce Development, Diversity and Inclusion (WDDI) Committee were disappointed that the …

Lupus Patients Find Hope In the Face of Hardship

One and a half million and counting. That’s how many people suffer from lupus in …

Diversity in Biopharma Leadership Makes Dollars and Sense

A series of recent studies examining diversity and financial performance have fueled a growing insistence …

The Latest Good News on Prescription Drug Costs

Two-hundred biotech allies from more than 40 different states visited Washington D.C. this week. These …

Orrin Hatch Is an Historic Figure in Biotechnology

As BIO CEO, everywhere I go – including Tokyo and Hong Kong last month – …